Literature DB >> 18804115

Induction of MuRF1 is essential for TNF-alpha-induced loss of muscle function in mice.

Volker Adams1, Norman Mangner, Alexander Gasch, Christian Krohne, Stephan Gielen, Stephanie Hirner, Hermann-Josef Thierse, Christian C Witt, Axel Linke, Gerhard Schuler, Siegfried Labeit.   

Abstract

BACKGROUND: Humoral circulating inflammatory cytokines such as tumor necrosis factor alpha (TNF-alpha) can impair skeletal muscle contractility. Furthermore, TNF-alpha expression correlates with elevated levels of atrogin-like muscle-specific ubiquitin E3 ligases, which are presumed to mediate muscle protein breakdown and atrophy. However, the casual relationships between MuRF1 and TNF-alpha and their relative contributions to muscle function impairment are not known.
METHODS: TNF-alpha or saline was injected into either C57Bl6 or MuRF1(-/-) mice. After 16-24 h, the expression of MuRF1 in skeletal muscle was quantified by quantitative reverse transcription-PCR and Western blot analysis. Muscle function was measured in an organ bath. To obtain a broader overview on potential alterations, two-dimensional gel electrophoresis was performed.
RESULTS: Wild-type animals injected with TNF-alpha had higher MuRF1 mRNA expression (saline versus TNF-alpha: 56.6+/-12.1 versus 133.6+/-30.3 arbitrary units; p<0.05) and protein expression (saline versus TNF-alpha: 0.38+/-0.11 versus 1.07+/-0.25 arbitrary units; p<0.05) as compared to saline-injected littermates. Furthermore, TNF-alpha reduced force development at 150 Hz by 25% in C57Bl6 animals (saline versus TNF-alpha: 2412+/-120 versus 1799+/-114 g/cm(2); p<0.05), but not in MuRF1(-/-) mice (saline versus TNF-alpha: 2424+/-198 versus 2431+/-180 g/cm(2); p=NS). Proteome analysis revealed a significant down-regulation of fast skeletal muscle troponin T in wild-type animals treated with TNF-alpha as compared to MuRF1(-/-) mice that received TNF-alpha.
CONCLUSION: The results of this study demonstrate for the first time that TNF-alpha-induced reduction in skeletal muscle force development depends on the induction of the atrophy-related E3 ubiquitin ligase MuRF1. A link for the reduction in muscle force may be the TNF-alpha/MuRF1-mediated down-regulation of fast skeletal muscle troponin T.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18804115     DOI: 10.1016/j.jmb.2008.08.087

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  51 in total

Review 1.  Respiratory and limb muscle dysfunction in pulmonary arterial hypertension: a role for exercise training?

Authors:  Marios Panagiotou; Andrew J Peacock; Martin K Johnson
Journal:  Pulm Circ       Date:  2015-09       Impact factor: 3.017

2.  Human skeletal muscle type 1 fibre distribution and response of stress-sensing proteins along the titin molecule after submaximal exhaustive exercise.

Authors:  Satu O A Koskinen; Heikki Kyröläinen; Riina Flink; Harri P Selänne; Sheila S Gagnon; Juha P Ahtiainen; Bradley C Nindl; Maarit Lehti
Journal:  Histochem Cell Biol       Date:  2017-07-15       Impact factor: 4.304

3.  TNF/TNFR1 signaling mediates doxorubicin-induced diaphragm weakness.

Authors:  Laura A A Gilliam; Jennifer S Moylan; Leonardo F Ferreira; Michael B Reid
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-11-19       Impact factor: 5.464

4.  Tumor necrosis factor inhibits mesenchymal stem cell differentiation into osteoblasts via the ubiquitin E3 ligase Wwp1.

Authors:  Lan Zhao; Jian Huang; Hengwei Zhang; Yi Wang; Lydia E Matesic; Masahiko Takahata; Hani Awad; Di Chen; Lianping Xing
Journal:  Stem Cells       Date:  2011-10       Impact factor: 6.277

Review 5.  Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx/atrogin-1.

Authors:  Sue C Bodine; Leslie M Baehr
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-08-05       Impact factor: 4.310

6.  Doxorubicin acts through tumor necrosis factor receptor subtype 1 to cause dysfunction of murine skeletal muscle.

Authors:  Laura A A Gilliam; Leonardo F Ferreira; Joseph D Bruton; Jennifer S Moylan; Håkan Westerblad; Daret K St Clair; Michael B Reid
Journal:  J Appl Physiol (1985)       Date:  2009-09-24

7.  Differential genomic responses in old vs. young humans despite similar levels of modest muscle damage after resistance loading.

Authors:  Anna E Thalacker-Mercer; Louis J Dell'Italia; Xiangqin Cui; James M Cross; Marcas M Bamman
Journal:  Physiol Genomics       Date:  2009-11-10       Impact factor: 3.107

8.  MG132-mediated inhibition of the ubiquitin-proteasome pathway ameliorates cancer cachexia.

Authors:  Liuping Zhang; Hua Tang; Yao Kou; Rui Li; Yueyong Zheng; Qiang Wang; Xiaoyu Zhou; Liangbin Jin
Journal:  J Cancer Res Clin Oncol       Date:  2013-03-28       Impact factor: 4.553

Review 9.  Cachexia in chronic heart failure: endocrine determinants and treatment perspectives.

Authors:  Norman Mangner; Yae Matsuo; Gerhard Schuler; Volker Adams
Journal:  Endocrine       Date:  2012-08-19       Impact factor: 3.633

10.  Reversal of muscle atrophy by Zhimu and Huangbai herb pair via activation of IGF-1/Akt and autophagy signal in cancer cachexia.

Authors:  Pengwei Zhuang; Jinbao Zhang; Yan Wang; Mixia Zhang; Lili Song; Zhiqiang Lu; Lu Zhang; Fengqi Zhang; Jing Wang; Yanjun Zhang; Hongjun Wei; Hongyan Li
Journal:  Support Care Cancer       Date:  2015-08-18       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.